Shares of Meme Stock Cassava Sheds 30% Following Concerns of Trial Results
(Bloomberg) Cassava Sciences Inc. stock recorded a 30% plunge after a former SEC lawyer raised concerns over the integrity of its trial results for an experimental Alzheimer drug. Former SEC’s…